Replies to post #101642 on Biotech Values

[ThomasS]

O/T: "But most of the MNTA investors on this board are small timers..." What is your point?
This "small-timer" was also burned: In the Fall of 2008/Spring 2009

1. I failed to buy BAC at $3 when Big-timers knew bankruptcy was imminent.
2. I failed to buy AXP at $10 when Big-timers knew that all Green/Gold/Platinum cards would be shredded.
3. I failed to buy GE at $7 when Big-timers knew they were failing.
4. I failed to buy C at $1 when Big-timers knew they were finished.
5. I failed to buy DNDN at $3 when many of us thought it a scam.

Want more theorem's? What theorem do you derive from today's MNTA market cap? I only deal with Axioms:
MNTA has the ONLY FDA approval for AB-rated generic Lovenox and Sandoz is stuffing the channel.
Fire away...

BTW, irt some posters "worries" about supply constraints and ramping of production, I believe those worries to be innocently misguided. Sandoz has had years to mull this issue and I'm quite confident it will not be a limiting factor going forward. Besides, they had substantial stock on hand for immediate launch and taking of significant market share from Day 1.

[go seek]

your point is noted...
but you should give even the small timers on this board some credit as to their ability to assess risk and reward. Most here are not novices in investing the market.

regards,

[oldberkeley]

On behalf of all the "small timers" here, I deeply resent that discriminatory and pejorative term; we prefer Investment Minimalists.

:-)